OBJECTIVES: To determine the prevalence and clinical significance of documented bacteriuria and/or urinary tract infection in an interstitial cystitis/painful bladder syndrome (IC/PBS) population. METHODS: Urine cultures were obtained at the initial assessment (documentation of sterile urine mandatory at diagnosis) and during routine follow-up, at each active treatment visit, and during and after the presentation and treatment of symptom flares in consecutively assessed female patients with IC/PBS. At each visit, the following questionnaires were completed: the O'Leary-Sant IC Symptom and Problem Index, the Pain Urgency Frequency questionnaire, and pain, frequency, and urgency Likert scales (0-10). RESULTS: A total of 100 patients with IC were followed up for 2 years. Of these 100 patients, 31 (31%) had ≥ 1 documented positive urine culture with a traditional uropathogen (mean 1.8, range 1-5). No difference was seen in the patients identified with bacteriuria and those without bacteriuria in age, symptom duration, O'Leary-Sant IC Symptom and Problem Indexes, Pain Urgency Frequency questionnaire, or pain, frequency, and urgency Likert scales. No correlation was found between the number of bacteriuria episodes and any symptom index evaluated. No significant difference was seen in any of the symptom indexes evaluated at baseline, during the bacteriuria episodes, or after successful bacterial eradication in the group identified with bacteriuria. CONCLUSIONS: The presence of bacteriuria can be documented in an IC/PBS population of women whose urine has frequently been cultured; however, the patients with bacteriuria did not differ from those without evidence of bacteriuria, the bacteriuria episodes did not appear to be associated with the symptom flares, and antibiotic treatment of documented bacteriuria was not associated with significant IC/PBS-related symptom amelioration.
OBJECTIVES: To determine the prevalence and clinical significance of documented bacteriuria and/or urinary tract infection in an interstitial cystitis/painful bladder syndrome (IC/PBS) population. METHODS: Urine cultures were obtained at the initial assessment (documentation of sterile urine mandatory at diagnosis) and during routine follow-up, at each active treatment visit, and during and after the presentation and treatment of symptom flares in consecutively assessed female patients with IC/PBS. At each visit, the following questionnaires were completed: the O'Leary-Sant IC Symptom and Problem Index, the Pain Urgency Frequency questionnaire, and pain, frequency, and urgency Likert scales (0-10). RESULTS: A total of 100 patients with IC were followed up for 2 years. Of these 100 patients, 31 (31%) had ≥ 1 documented positive urine culture with a traditional uropathogen (mean 1.8, range 1-5). No difference was seen in the patients identified with bacteriuria and those without bacteriuria in age, symptom duration, O'Leary-Sant IC Symptom and Problem Indexes, Pain Urgency Frequency questionnaire, or pain, frequency, and urgency Likert scales. No correlation was found between the number of bacteriuria episodes and any symptom index evaluated. No significant difference was seen in any of the symptom indexes evaluated at baseline, during the bacteriuria episodes, or after successful bacterial eradication in the group identified with bacteriuria. CONCLUSIONS: The presence of bacteriuria can be documented in an IC/PBS population of women whose urine has frequently been cultured; however, the patients with bacteriuria did not differ from those without evidence of bacteriuria, the bacteriuria episodes did not appear to be associated with the symptom flares, and antibiotic treatment of documented bacteriuria was not associated with significant IC/PBS-related symptom amelioration.
Authors: Kemal Ener; Murat Keske; Mustafa Aldemir; Muhammet Fuat Özcan; Emrah Okulu; Asım Özayar; Merve Ergin; Ömer Gökhan Doluoğlu; Serdar Çakmak; Özcan Erel Journal: Int Urol Nephrol Date: 2015-06-07 Impact factor: 2.370
Authors: J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis Journal: Nat Rev Urol Date: 2019-03 Impact factor: 14.432
Authors: Siobhan Sutcliffe; Thomas Jemielita; H Henry Lai; Gerald L Andriole; Catherine S Bradley; J Quentin Clemens; Robert Gallop; Thomas M Hooton; Karl J Kreder; John N Krieger; John W Kusek; Jennifer Labus; M Scott Lucia; Sean Mackey; Bruce D Naliboff; Nancy A Robinson; Larissa V Rodriguez; Alisa Stephens-Shields; Adrie van Bokhoven; Kathleen Y Wolin; Yan Yan; Claire C Yang; J Richard Landis; Graham A Colditz Journal: J Urol Date: 2017-12-27 Impact factor: 7.450
Authors: Siobhan Sutcliffe; Catherine S Bradley; James Quentin Clemens; Aimee S James; Katy S Konkle; Karl J Kreder; Hing Hung Henry Lai; Sean C Mackey; Cody P Ashe-McNalley; Larissa V Rodriguez; Edward Barrell; Xiaoling Hou; Nancy A Robinson; Chris Mullins; Sandra H Berry Journal: Int Urogynecol J Date: 2015-03-20 Impact factor: 2.894
Authors: J Curtis Nickel; Alisa Stephens; J Richard Landis; Chris Mullins; Adrie van Bokhoven; M Scott Lucia; Garth D Ehrlich Journal: J Urol Date: 2015-09-26 Impact factor: 7.450
Authors: Siobhan Sutcliffe; Graham A Colditz; Ratna Pakpahan; Catherine S Bradley; Melody S Goodman; Gerald L Andriole; H Henry Lai Journal: Neurourol Urodyn Date: 2013-11-23 Impact factor: 2.696
Authors: Roopali Roy; Alisa J Stephens; Cassandra Daisy; Lauren Merritt; Craig W Newcomb; Jiang Yang; Adelle Dagher; Adam Curatolo; Monisha Sachdev; Brendan McNeish; Richard Landis; Adrie van Bokhoven; Andrew El-Hayek; John Froehlich; Michel A Pontari; David Zurakowski; Richard S Lee; Marsha A Moses Journal: J Urol Date: 2020-10-07 Impact factor: 7.450